Japan’s 1st Sublingual Immunotherapy Wins Approval: Torii

January 21, 2014
Torii Pharmaceutical said on January 17 that its Cedartolen Sublingual Drop obtained marketing approval the same day for Japanese cedar pollinosis (allergen immunotherapy), becoming the first sublingual immunotherapy approved in Japan. The new product will be pain-free as compared to...read more